LCAR-B38M Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma
Clinical trial NCT03090659 · UNKNOWN
Trial details
- NCT number
- NCT03090659
- Sponsor
- Nanjing Legend Biotech Co.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-02
- Primary completion
- 2023-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.